Pancragen is a synthetic bioregulator peptide gaining interest for its potential role in supporting pancreatic function and metabolic health in scientific research. With a specific amino acid sequence—Lys-Glu-Asp-Trp (KEDW)—Pancragen belongs to a group of short peptides that may influence cellular repair and organ-specific regeneration, particularly in the pancreas.
In this article, we explore Pancragen, its theoretical applications, the science behind it, and the types of research that are currently studying it.
What Is Pancragen?
Pancragen is a tetrapeptide bioregulator studied for its potential targeted effects on the pancreas. Its chemical and structural data are as follows:
• Sequence: H-Lys-Glu-Asp-Trp-OH
• Molecular Formula: C₂₈H₃₈N₆O₉
• Molecular Weight: 576.25 g/mol
• Purity (as seen in typical research-grade samples): 99%
• Form: Lyophilised powder
This short peptide sequence is theorised to interact with DNA sequences in pancreatic cells, potentially influencing gene expression related to maintaining normal pancreatic function.
Why Is Pancragen Being Researched?
Pancragen is of particular interest in studies investigating:
• Endocrine Function Support – Research is exploring how Pancragen may support the regulation of insulin and glucagon secretion.
• Blood Sugar Balance – It has been studied in models focused on glucose metabolism and regulating blood sugar levels.
• Age-Related Metabolic Changes – As part of the broader family of peptide bioregulators, Pancragen is also examined for its potential role in reducing metabolic decline due to ageing.
This peptide is one of several developed initially during Soviet-era peptide research, where organ-specific peptides were investigated for their regenerative potential.
Theoretical Dosage in Research Settings
Pancragen is used exclusively in laboratory environments and is not intended for human use. Scientific literature and hypothetical models typically explore it in cycles ranging from 10 to 15 days.
• Example Theoretical Dosage:
Depending on the experimental setup, 100–200 mcg per day in model organisms.
These figures are purely illustrative and based on existing preclinical data. They are not intended as guidance for any form of therapeutic application.
Key Points at a Glance
• Pancragen is a tetrapeptide bioregulator with a specific focus on the pancreas.
• Research explores its role in insulin signalling, blood sugar regulation, and age-related metabolic function.
• It has a well-defined peptide sequence: KEDW.
• All exploration of Pancragen is confined to non-human, laboratory-based environments.
Disclaimer: This article is intended for informational and educational purposes only. The compound discussed is not approved for human or veterinary use and is strictly for laboratory research. No medical claims are made or implied.
